RICHARD BERGER: Open Payments
NPI 1992462758 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 105 payments from 19 companies in 2025. Trend: 2023 $1,195 · 2024 $2,122 · 2025 $2,279
Food & beverage: $1,966Travel & lodging: $314
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 5 | $514 |
| AstraZeneca Pharmaceuticals LP | 12 | $426 |
| GlaxoSmithKline, LLC. | 32 | $381 |
| GENZYME CORPORATION | 12 | $238 |
| Regeneron Healthcare Solutions, Inc. | 12 | $159 |
| Amgen Inc. | 9 | $148 |
| Verona Pharma, Inc. | 5 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Grifols USA, LLC | 2 | $40 |
| Insmed, Inc. | 2 | $37 |
Products named: INSPIRE, TEZSPIRE, DUPIXENT, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA, ARALAST.
Industry payments across NJ — which companies pay providers there.
